Clinical Trials in Pittsburgh

Showing 12761-12780 of 18,076 trials

Obalon Balloon System Pivotal IDE (SMART) Trial

NCT02235870

This pivotal trial of the Obalon Balloon System is intended to generate safety and effectiveness data required to support a future marketing application. The trial has been designed to evaluate a 6-month use of the Obalon Balloon System as an adjunct to a nutrition and lifestyle behavior modification program. Weight loss will be evaluated after the 6-month course to determine if a specific predefined superiority margin can be achieved in the device group compared to a sham-control group.

Obesity

Obalon Therapeutics, Inc.711 participantsStarted Feb 2015

Scottsdale, Arizona, United States • Anaheim, California, United States • Coronado, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00441090

The purpose of this study is to determine the efficacy, safety and tolerability, of AKR-501 (avatrombopag) tablets, as compared to placebo, in the treatment of participants with chronic Idiopathic Thrombocytopenic Purpura (ITP).

Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic

Eisai Inc.64 participantsStarted Feb 2007

Anaheim, California, United States • Bakersfield, California, United States • Concord, California, United States +22 more locations

Obalon Balloon System Pivotal IDE (SMART) Trial

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Find Trials by Condition in Pittsburgh

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Investigating the Effect of Vortioxetine in Adult ADHD Patients

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Third International Study on Mechanical Ventilation

The Captivator EMR Registry

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel